175 related articles for article (PubMed ID: 17882269)
1. Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis.
Belsõ N; Széll M; Pivarcsi A; Kis K; Kormos B; Kenderessy AS; Dobozy A; Kemény L; Bata-Csörgõ Z
J Invest Dermatol; 2008 Mar; 128(3):634-42. PubMed ID: 17882269
[TBL] [Abstract][Full Text] [Related]
2. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.
Bartkova J; Lukas J; Strauss M; Bartek J
Oncogene; 1998 Aug; 17(8):1027-37. PubMed ID: 9747882
[TBL] [Abstract][Full Text] [Related]
4. Leptin-mediated decrease of cyclin A2 and increase of cyclin D1 expression: relevance for the control of prepubertal rat Leydig cell division and differentiation.
Fombonne J; Charrier C; Goddard I; Moyse E; Krantic S
Endocrinology; 2007 May; 148(5):2126-37. PubMed ID: 17303663
[TBL] [Abstract][Full Text] [Related]
5. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo.
Sun W; Lee DK; Lee CC; Kim K
Mol Reprod Dev; 1996 Apr; 43(4):414-20. PubMed ID: 9052931
[TBL] [Abstract][Full Text] [Related]
7. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.
Ajchenbaum F; Ando K; DeCaprio JA; Griffin JD
J Biol Chem; 1993 Feb; 268(6):4113-9. PubMed ID: 8382693
[TBL] [Abstract][Full Text] [Related]
8. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
9. Ethanol and acetone stimulate the proliferation of HaCaT keratinocytes: the possible role of alcohol in exacerbating psoriasis.
Farkas A; Kemény L; Széll M; Dobozy A; Bata-Csörgo Z
Arch Dermatol Res; 2003 Jun; 295(2):56-62. PubMed ID: 12720008
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
Geum D; Sun W; Paik SK; Lee CC; Kim K
Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
[TBL] [Abstract][Full Text] [Related]
11. Proliferating keratinocytes are putative sources of the psoriasis susceptibility-related EDA+ (extra domain A of fibronectin) oncofetal fibronectin.
Széll M; Bata-Csörgo Z; Koreck A; Pivarcsi A; Polyánka H; Szeg C; Gaál M; Dobozy A; Kemény L
J Invest Dermatol; 2004 Sep; 123(3):537-46. PubMed ID: 15304094
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells.
Javier AF; Bata-Csorgo Z; Ellis CN; Kang S; Voorhees JJ; Cooper KD
J Clin Invest; 1997 May; 99(9):2094-9. PubMed ID: 9151781
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
Al-Aynati MM; Radulovich N; Ho J; Tsao MS
Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia.
Rodriguez-Puebla ML; LaCava M; Miliani De Marval PL; Jorcano JL; Richie ER; Conti CJ
Am J Pathol; 2000 Sep; 157(3):1039-50. PubMed ID: 10980142
[TBL] [Abstract][Full Text] [Related]
15. G1-phase regulators, cyclin D1, cyclin D2, and cyclin D3: up-regulation at gastrulation and dynamic expression during neurulation.
Wianny F; Real FX; Mummery CL; Van Rooijen M; Lahti J; Samarut J; Savatier P
Dev Dyn; 1998 May; 212(1):49-62. PubMed ID: 9603423
[TBL] [Abstract][Full Text] [Related]
16. Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication.
Gong J; Traganos F; Darzynkiewicz Z
Cell Growth Differ; 1995 Nov; 6(11):1485-93. PubMed ID: 8562487
[TBL] [Abstract][Full Text] [Related]
17. Selective usage of D-type cyclins in lymphoid malignancies.
Suzuki R; Kuroda H; Komatsu H; Hosokawa Y; Kagami Y; Ogura M; Nakamura S; Kodera Y; Morishima Y; Ueda R; Seto M
Leukemia; 1999 Sep; 13(9):1335-42. PubMed ID: 10482983
[TBL] [Abstract][Full Text] [Related]
18. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
[TBL] [Abstract][Full Text] [Related]
19. Development of mice expressing a single D-type cyclin.
Ciemerych MA; Kenney AM; Sicinska E; Kalaszczynska I; Bronson RT; Rowitch DH; Gardner H; Sicinski P
Genes Dev; 2002 Dec; 16(24):3277-89. PubMed ID: 12502747
[TBL] [Abstract][Full Text] [Related]
20. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo.
Mullany LK; White P; Hanse EA; Nelsen CJ; Goggin MM; Mullany JE; Anttila CK; Greenbaum LE; Kaestner KH; Albrecht JH
Cell Cycle; 2008 Jul; 7(14):2215-24. PubMed ID: 18635970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
